期刊文献+

卵巢癌组织中Yes-相关蛋白和p73的表达及其临床意义 被引量:5

Expression and clinical significance of Yes-related protein and p73 in ovarian cancer tissue
下载PDF
导出
摘要 目的探讨卵巢癌组织中Yes-相关蛋白(YAP)和p73的表达及其意义。方法选取2013年1月至2016年6月在我院治疗的卵巢癌患者81例(病例组),同时选取卵巢良性肿瘤患者70例作为对照组,检测两组患者的YAP和p73蛋白表达。结果病例组患者的YAP和p73蛋白阳性表达率分别为60.49%和67.90%,明显高于对照组的11.43%和30.00%,差异均有统计学意义(P<0.05);病例组Ⅲ~Ⅳ期患者的YAP蛋白和p73蛋白阳性率为79.49%和82.05%,明显高于Ⅰ~Ⅱ期的42.86%和54.76%,差异均有统计学意义(P<0.05);病例组病理分级G3患者YAP蛋白和p73蛋白阳性率为71.67%和80.00%,明显高于G1和G2级的28.57%和33.33%,差异均有统计学意义(P<0.05);淋巴结转移患者的p73蛋白阳性率为86.96%,明显高于无淋巴结转移的60.34%,差异均有统计学意义(P<0.05)。结论卵巢癌组织YAP和p73蛋白表达增强,可能参与了卵巢癌的发生发展,其中p73与卵巢癌淋巴转移有一定关系。 Objective To investigate the expression and significance of Yes-associated protein (YAP) and p73 in ovarian cancer tissue. Methods From January 2013 to June 2016, a total of 81 patients with ovarian cancer (case group) in our hospital from January 2013 to June 2016 were selected. At the same time, 70 cases of ovarian benign tu-mor patients were enrolled as the control group. The expression of YAP and p73 protein were detected between the two groups. Results The positive expression rates of YAP and p73 protein in case group were respectively 60.49% and 67.90%, which were significantly higher than 11.43%and 30.00%in the control group (P〈0.05). The positive rates of YAP protein and p73 protein in stageⅢandⅣwere 79.49%and 82.05%, which were significantly higher than 42.86%and 54.76%in the stageⅠ~Ⅱ, with statistically significant difference (P〈0.05). The positive rates of YAP protein and p73 protein were 71.67%and 80.00%in pathological grading G3 patients, which were significantly higher than 28.57%and 33.33%in pathological grading G1 and G2 pateints (P〈0.05). The positive rate of p73 protein in patients with lymph node metastasis was 86.96%, which was significantly higher than 60.34% in patients without lymph node metastasis, with statistically significant difference (P〈0.05). Conclusion YAP and p73 protein expression in ovarian cancer tissue are enhanced, which may be involved in the occurrence and development of ovarian cancer. p73 is related to lymph node metastasis of ovarian cancer.
出处 《海南医学》 CAS 2017年第10期1560-1562,共3页 Hainan Medical Journal
基金 湖北省自然科学基金(编号:2014FFB04510)
关键词 卵巢癌 Yes-相关蛋白 P73蛋白 病理特征 Ovarian cancer Yes-associated protein (YAP) p73 protein Pathological characteristics
  • 相关文献

参考文献8

二级参考文献120

  • 1曾定元,沈铿.卵巢正常大小癌综合征的研究进展[J].中华医学杂志,2005,85(16):1149-1151. 被引量:5
  • 2Davidson B, Reich R, Trope CG, et aL New determinates of disease progression and outcome in metastatic ovarian carcinoma. Histol Histopathol, 2010, 25:1591-1609. 被引量:1
  • 3L - Mao I-IL, Liu PS, Zheng JF, et al. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro. Pharmacol Res, 2007, 56:483-492. 被引量:1
  • 4Kelly MG, Alvero AB, Chen R, et al. TLR-.4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res, 2006, 66:3859-3868. 被引量:1
  • 5Szajnik M, Szczepanski MJ, Czystowska M, et al. TLR4 signaling induced by lipopolysacchafide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene, 2009, 28: 4353-4363. 被引量:1
  • 6Silasi DA, Alvero AB, Illuzzi J, et al. MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer. Yale J Biol Med, 2006, 79:153-163. 被引量:1
  • 7Wang AC, Su QB, Wu FX, et al. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur J Clin Invest, 2009, 39 : 257-164. 被引量:1
  • 8Kilieen SD, Wang JH, Andrews EJ, et al. Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? Br J Cancer, 2006, 95:247-252. 被引量:1
  • 9Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature, 2008, 454: 436--444. 被引量:1
  • 10Alvero AB, Chen R, Fu HH, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle, 2009, 8:158-166. 被引量:1

共引文献65

同被引文献53

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部